Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.
During the past decade, the age-adjusted mortality rate for endometrial cancer (EC) increased 1.9% annually with TP53 mutant (TP53-mu) EC disproportionally represented in advanced disease and deaths. Therefore, we aimed to assess pivotal molecular parameters that differentiate clinical outcomes in h...
Main Authors: | Jesus Gonzalez Bosquet, Qing Zhang, William A Cliby, Jamie N Bakkum-Gamez, Ling Cen, Sean C Dowdy, Mark E Sherman, S John Weroha, Amy C Clayton, Benjamin R Kipp, Kevin C Halling, Fergus J Couch, Karl C Podratz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0245664 |
Similar Items
-
Preserving fertility in young patients with endometrial cancer: current perspectives
by: Kalogera E, et al.
Published: (2014-07-01) -
Disparities and interventions in the timeliness of endometrial cancer diagnosis and treatment in the United States: a scoping review protocol
by: Anna J. Najor, et al.
Published: (2021-04-01) -
Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literature
by: Sharon Kim, et al.
Published: (2015-04-01) -
Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature
by: Joy M. Beissel, et al.
Published: (2014-12-01) -
Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
by: Chun-E Ren, et al.
Published: (2015-03-01)